Edwards Lifesciences Corporation (EW)
$86.39+1.38%Close
SELLBEAR · day 25
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $49.7B
- Beta
- 0.86
- P/E (TTM)
- 49.70
- Short % float
- 1.68%
- Days to cover
- 2.5
- SI change
- +5.0%
- 1W
- -0.96%
- 1M
- +2.39%
- vs SPY 1W
- -1.38%
- vs SPY 1M
- +0.33%
Industry peers
FMP comparable companies · ranked by market cap
- ISRGBUYIntuitive Surgical, Inc.$149.8BRECOVERYQ 29$423.96+0.87%
- 688617.SSAPT Medical Inc.$34.4B$242.85
- SMMNYSiemens Healthineers AG$24.5B$21.95
- TRUMYTerumo Corporation$21.1B$14.28
- OCPNFOlympus Corporation$13.4B$12.13
- PENSELLPenumbra, Inc.$12.6BBULLQ 27$319.40+0.49%
- GNGBYGetinge AB (publ)$6.9B$25.32
- LIVNSELLLivaNova PLC$4.2BBEARQ 3$76.39+1.15%
- AORTSELLArtivion, Inc.$1.0BCRISISQ 3$21.26+2.49%
- AVRSELLAnteris Technologies Global Corp.$658MCRISISQ 18$6.77-1.77%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on EW?
- LOPJLB’s latest quantitative signal on Edwards Lifesciences Corporation (EW) is SELL in a BEAR regime. Signals are updated daily.
- What market regime is EW in?
- Edwards Lifesciences Corporation (EW) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does Edwards Lifesciences Corporation (EW) do?
- Edwards Lifesciences Corporation is a global medical technology firm specializing in sophisticated products and technologies for structural heart conditions, alongside critical care and surgical patient monitoring. With operations spanning the United States, Europe, Japan, and various international territories, the company offers a comprehensive suite of solutions. Their structural heart diseas…